← All stocks

uniQure N.V.

QURE No buying or selling
CIK 0001590560 #1650 in the set updated 18 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

12 insiders · 0 transactions
35.2×

Matthew Kapusta holds 35.2 times base salary in stock. $23.83M of shares against $676.17K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew Kapusta last reported holding, valued at $45.89, the price Ordinary Shares was last bought or sold at on the open market here, on 2 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Kapusta Matthew C
CEO, Managing Director
519,227
$23.83M
−12.1%
KLEMT CHRISTIAN
Chief Financial Officer
226,581
$10.40M
+37.5%
Abi-Saab Walid
Chief Medical Officer
148,235
$6.80M
+28.6%
Potts Jeannette
Chief Legal Officer
133,246
$6.11M
+45.1%
O'Keefe Kylie
Chief Customer & Strat Officer
108,864
$5.00M
+3.7%
Balachandran Madhavan
Director
43,254
$1.98M
+35.9%
Springhorn Jeremy P.
Director
43,251
$1.98M
+35.9%
Meek David D.
Director
39,747
$1.82M
+40.3%
POST LEONARD E
Director
35,494
$1.63M
+47.4%
Jacques Rachelle Suzanne
Director
33,903
$1.56M
+50.8%
Gut Robert
Director
32,259
$1.48M
−36.9%
Kaye Jack
Director
25,996
$1.19M
+78.3%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 31 Jan 2017